Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.
Prostate gland
Ahmed Sakr,
Urology MD
By
Zagazig Urology Department
Anatomy of the prostate
•
The prostate surrounds the bladder outlet & the
beginning of male urethra.
•
Its shape is like a...
Zonal anatomy:
•
TZ (the commonest site for BPH)
•
CZ
•
PZ (the commonest site for
prostatic carcinoma)
•
Anterior fibro-m...
Benign prostatic hyperplasia
“Senile enlargement of the prostate”
•
The commonest tumor of the prostate
•
Affects about ⅔ ...
Histology:
•
Hyperplasic acini
•
Variable in size
•
Lined with one or more layers of cells
•
some acini contain corpora am...
Pathologic effect:
•
Urethra: compressed, stretched, elongated & may
be tortuous
•
Bladder:
-
Bladder → Hypertrophied wall with ↑ pressure inside →
cellule & diverticula
-
Bladder decompensation → urine ...
•
Upper tract: Hydroureter & hydronephrosis &
may lead to renal insufficiency
Clinical picture: (LUTS obstructive or irritative)
•
Obstructive : hesitancy, weak stream, interrupted
stream & urine rete...
Physical examination:
•
Abdominal mass (hydronephrosis)
•
Pelvic mass (retained bladder)
•
DRE:
1. Symmetrical or asymmetr...
Investigations:
A. Basic investigations:
1. Urinalysis
2. Serum creatinine
3. PSA:
•
Normal level → 0-4 ngml
•
BPH → 4-10 ...
B. Additional investigations:
•
IVP
•
Uroflowmetry
•
Estimation of post-voiding residual urine
•
Cystoscopy
Complications:
1. Hematuria
2. Urine retention (acute or chronic)
3. Infection
4. Stone formation
5. uremia
Treatment:
1. Watchful waiting: ( in mild symptoms)
•
↓ fluid intake
•
Timed voiding
•
Avoidance of constipation
•
Avoid e...
2. Medical treatment:
-
Indications: Bothersome symptoms with no complications
-
Drugs:
•
α – adrenergic blockers (Doxazoc...
3. Surgical treatment:
•
Indications:
1. Recurrent attacks of acute retention
2. Hematuria
3. Recurrent urinary tract infe...
Prostate cancer
Etiology: Unknown
Risk factors: Family history, high fat diet & racial
factors
Pathology:
-
Gross: Hard no...
Clinical picture:
•
Asymptomatic & discovered accidentally
•
Symptoms of metastasis without urinary symptoms
(occult carci...
Diagnosis:
1. DRE
2. Elevated PSA
3. Prostatic biopsy
4. Other markers as serum acid phosphatase & serum
alkaline phosphat...
Treatment:
1. Watchful waiting.
2. Radical surgery.
3. Radiotherapy: External or brachytherapy
4. Hormonal therapy: in adv...
Benign Prostate Hyperplasia & Prostate Cancer
Prochain SlideShare
Chargement dans…5
×

Benign Prostate Hyperplasia & Prostate Cancer

2 271 vues

Publié le

Property of Prof Dr. Ahmed Sakr, Department of Urology, Faculty of Medicine, University of Zagazig, Egypt

Publié dans : Santé & Médecine
  • Identifiez-vous pour voir les commentaires

Benign Prostate Hyperplasia & Prostate Cancer

  1. 1. Prostate gland Ahmed Sakr, Urology MD By Zagazig Urology Department
  2. 2. Anatomy of the prostate • The prostate surrounds the bladder outlet & the beginning of male urethra. • Its shape is like a chestnut or inverted cone. • It measures 3 × 4 × 2 cm & weighs about 18 gm. • Relations:
  3. 3. Zonal anatomy: • TZ (the commonest site for BPH) • CZ • PZ (the commonest site for prostatic carcinoma) • Anterior fibro-muscular stroma Clinically : The prostate has 2 lat. Lobes separated by a central sulcus and a median lobe which may project into the cavity of the U.B.
  4. 4. Benign prostatic hyperplasia “Senile enlargement of the prostate” • The commonest tumor of the prostate • Affects about ⅔ of men over 50 y. Etiology: 1- Unknown 2- Aging 3- Normal testosterone Pathology: • From TZ or peri-urethral region • As adenoma enlarges, it compresses the normal prostatic tissue forming a false capsule with a line of cleavage.
  5. 5. Histology: • Hyperplasic acini • Variable in size • Lined with one or more layers of cells • some acini contain corpora amylacea • The fibro-muscular stroma shows hypertrophy BPH Normal prostate
  6. 6. Pathologic effect: • Urethra: compressed, stretched, elongated & may be tortuous
  7. 7. • Bladder: - Bladder → Hypertrophied wall with ↑ pressure inside → cellule & diverticula - Bladder decompensation → urine retention (acute or chronic)
  8. 8. • Upper tract: Hydroureter & hydronephrosis & may lead to renal insufficiency
  9. 9. Clinical picture: (LUTS obstructive or irritative) • Obstructive : hesitancy, weak stream, interrupted stream & urine retention • Irritative : ↑ frequency, urgency & urge incontinence - Obstructive symptoms occur first but with infection & stone formation irritative symptoms become manifest
  10. 10. Physical examination: • Abdominal mass (hydronephrosis) • Pelvic mass (retained bladder) • DRE: 1. Symmetrical or asymmetrical enlargement 2. Preserved sulcus 3. Smooth surface 4. Sliding rectal mucosa over the gland 5. Consistency like that of contracted thenar eminence
  11. 11. Investigations: A. Basic investigations: 1. Urinalysis 2. Serum creatinine 3. PSA: • Normal level → 0-4 ngml • BPH → 4-10 ngml • > 10 ngml may indicate cancer 4. U/S: • Abdominal • TRUS
  12. 12. B. Additional investigations: • IVP • Uroflowmetry • Estimation of post-voiding residual urine • Cystoscopy
  13. 13. Complications: 1. Hematuria 2. Urine retention (acute or chronic) 3. Infection 4. Stone formation 5. uremia
  14. 14. Treatment: 1. Watchful waiting: ( in mild symptoms) • ↓ fluid intake • Timed voiding • Avoidance of constipation • Avoid exposure to cold • Avoid diuretics & anti-cholinergic • Avoid sexual excitement
  15. 15. 2. Medical treatment: - Indications: Bothersome symptoms with no complications - Drugs: • α – adrenergic blockers (Doxazocin – Terazocin) They act by ↓ the tension of the smooth muscle of prostatic capsule • 5 – α reductase inhibitors (Finasteride): It inhibits the 5 – α reductase enzyme responsible for conversion of testosterone to DHT
  16. 16. 3. Surgical treatment: • Indications: 1. Recurrent attacks of acute retention 2. Hematuria 3. Recurrent urinary tract infection 4. Bladder stone or diverticula 5. Renal insufficiency • Routes of intervention: - Open surgery: Transvesical or retropubic - TUR-P 4. Minimally invasive techniques: • LASER prostatectomy • Prostatic balloon ablation • Prostatic stents • Thermotherapy
  17. 17. Prostate cancer Etiology: Unknown Risk factors: Family history, high fat diet & racial factors Pathology: - Gross: Hard nodular prostate, may invade the capsule or adjacent structures - Microscopic: Adenocarcinoma of varying degrees Spread: 1. Direct spread 2. Lymphatic spread 3. Blood spread
  18. 18. Clinical picture: • Asymptomatic & discovered accidentally • Symptoms of metastasis without urinary symptoms (occult carcinoma) • LUTS (shorter duration & progressive course)
  19. 19. Diagnosis: 1. DRE 2. Elevated PSA 3. Prostatic biopsy 4. Other markers as serum acid phosphatase & serum alkaline phosphatase 5. Plain X-ray spine for metastasis 6. Isotopic bone scan 7. CT scan 8. Cystoscopy
  20. 20. Treatment: 1. Watchful waiting. 2. Radical surgery. 3. Radiotherapy: External or brachytherapy 4. Hormonal therapy: in advanced cases Depends on androgen ablation by: • Bilateral orchiectomy • Oral estrogen • Antiandrogens

×